British American Tobacco PLC
BTI Details:
British American Tobacco PLC (NYSE: BTI) is a British multinational corporation that produces and sells cigarettes, tobacco, and other nicotine-containing products. Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans Neo, Vuse, Newport, Camel, and Natural American Spirit are among the company's leading brands. BTI has 2.29 billion American Depository Shares (ADS) listed and outstanding (each ADS representing one ordinary shares).
Latest News:
- Launched Virtual R&D Visitor Center: BTI announced on January 19, 2022, that it had launched a virtual R&D Visitor Experience, an online tour of its worldwide Research & Development (R&D) hub in Southampton, UK, that allows individuals to explore its cutting-edge science and innovation. The experience builds on its open and transparent approach to the research underlying its low-risk product line and efforts beyond nicotine.
- Foraying into Biotech Innovation: On January 7, 2022, the firm announced the formation of KBio Holdings Limited (KBio) to speed the research, development, and production of innovative medicines. KBio will draw on the existing and extensive plant-based technology capabilities of BAT, BTI's parent company, and Kentucky BioProcessing Inc (KBP), a BAT-owned US plant biologics firm.
H1FY21 Results:
- Flat Revenues: The company reported a slight decrease of 0.78% in total revenues to GBP 12.17 billion during H1FY21 (ended June 30, 2021) compared to GBP 12.27 billion during H1FY20.
- Slight decline in Net Income: BTI's net income decreased to GBP 3.33 billion during H1FY21 from GBP 3.54 billion during H1FY20.
- Cash Position and Debt Position: As of June 30, 2021, its cash and cash equivalents (including marketable investments) were GBP 3.35 billion, with a total debt of GBP 45.01 billion.
Key Risks:
- Regulatory & Taxation Risk: Tobacco makers are forced to conform with various regulatory frameworks worldwide, making the business highly regulated. These limits may limit BTI's ability to promote its products, putting its company and financial health at risk. Furthermore, BTI is vulnerable to unanticipated and significant increases in tobacco and nicotine-related taxes in its core markets, which could substantially impact its revenues and results of operations.
Outlook:
- Revenue Estimates: BTI forecasts revenue to expand by more than 5% in FY21, owing to robust growth in New Category products and a better global combustible volume outlook, fueled by emerging market recovery.
- Dividend Estimates: The company will maintain its dividend payout ratio of 65% and dividend growth in GBP terms while investing in business transformation and deleveraging the balance sheet to achieve a 3x adjusted net debt to adjusted EBITDA ratio by year's end.
Valuation Methodology: EV/EBITDA Multiple Based Relative Valuation
(Analysis by Kalkine Group)
* % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
Stock Recommendation:
BTI' share price has risen 26.16% in the past three months. We have valued the stock using the Price/Earnings multiple-based relative valuation methodology and arrived at a target price of USD 46.00. In addition, the company has an industry-leading profit profile, giving its stockholders a major competitive advantage.
Considering the company's proven track record, market dominance in the tobacco industry, launched R&D center, current valuation, and associated risks, we recommend a "Hold" rating on the stock at the current price of USD 43.62, down 0.27% as of February 04, 2022, at 10:12 AM ET.
Three-Year Technical Price Chart (February 04, 2022, 10:12 AM ET). Analysis by Kalkine Group
*All forecasted figures and Industry Information have been taken from REFINITIV.
*The reference data in this report has been partly sourced from REFINITIV.
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.